1 active not recruiting, 1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow DLBCL NOS: new trials by email Literature Review of DLBCL NOS trials Research Report on DLBCL NOS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies P-CD19CD20-ALLO1, Rimiducid - Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, High-grade B-cell Lymphoma | Phase 1 | Active not recruiting | Poseida Therapeutics, Inc. | 120 | 2024-04-16 | 2026-05-07 |
| Study of CAR-T Therapy in Older Patients Activities of Daily Living/ADLs, Instrumental Activity of Daily Living, Timed Up and Go - Lymphoma, Refractory B-Cell Lymphoma | Recruiting | Memorial Sloan Kettering Cancer Center | 154 | 2020-03-04 | 2026-04-07 |
Dendritic Cell Sarcoma, Interdigitating (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1) · Multiple Myeloma (1)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma, Non-Hodgkin (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Hematologic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Histiocytic Disorders, Malignant (1) · Histiocytosis (1)
Activities of Daily Living (1) · Blood Specimen Collection (1) · Neuropsychological Tests (1) · Trail Making Test (1)
Memorial Sloan Kettering Cancer Center (1) · Poseida Therapeutics, Inc. (1)
United States (2)
Richard Lin, MD, PhD (1) · Simon Heidegger, MD (1)